Risk of Lymphoma Associated with Anti-TNF Therapy in Patients with Inflammatory Bowel Disease: Implications for Therapy

被引：35

作者：

Dahmus, Jessica ^{[1
]}

Rosario, Michelle ^{[1
]}

Clarke, Kofi ^{[1
]}

机构：

[1] Penn State Milton S Hershey Med Ctr, Gastroenterol, Hershey, PA 17033 USA

来源：

CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY | 2020年 / 13卷

关键词：

malignancy; cancer; biologics; ulcerative colitis; Crohn's disease; hepatosplenic T-cell lymphoma; TUMOR-NECROSIS-FACTOR; EVIDENCE-BASED CONSENSUS; CROHNS-DISEASE; CANCER-RISK; THIOPURINES; INFLIXIMAB; IMMUNOMODULATORS; MALIGNANCIES; ANTAGONISTS; INFECTIONS;

D O I：

10.2147/CEG.S237646

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Anti-tumor necrosis factor alpha (ATA) therapy plays a significant role in the treatment of moderate to severe inflammatory bowel disease (IBD). There are concerns regarding risks associated with their use, including malignancy and, specifically, lymphoma. Many previous studies have sought to determine whether there is a true link between ATA therapy in IBD and development of lymphoma. However they have been hindered by short follow-up times, few cases, and confounding factors such as previous thiopurine exposure. This review seeks to update the literature by evaluating more recent studies assessing the link between ATA monotherapy and lymphoma development. It also summarizes findings of those studies and provides additional clinical guidance pertaining to this class of biologic therapy.

引用

页码：339 / 350

页数：12

共 44 条

[11] Managing Risks with Biologics [J].

Click B. ;

Regueiro M. .

Current Gastroenterology Reports, 2019, 21 (1)

[12] Lymphoma Risk and Overall Safety Profile of Adalimumab in Patients With Crohn's Disease With up to 6 Years of Follow-Up in the Pyramid Registry [J].

D'Haens, Geert ;

Reinisch, Walter ;

Panaccione, Remo ;

Satsangi, Jack ;

Petersson, Joel ;

Bereswill, Mareike ;

Arikan, Dilek ;

Perotti, Eva ;

Robinson, Anne M. ;

Kalabic, Jasmina ;

Alperovich, Gabriela ;

Thakkar, Roopal ;

Loftus, Edward V. .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 (06) :872-882

[13] Five-year Safety Data From ENCORE, a European Observational Safety Registry for Adults With Crohn's Disease Treated With Infliximab [Remicade®] or Conventional Therapy [J].

D'Haens, Geert ;

Reinisch, Walter ;

Colombel, Jean-Frederic ;

Panes, Julian ;

Ghosh, Subrata ;

Prantera, Cosimo ;

Lindgren, Stefan ;

Hommes, Daniel W. ;

Huang, Zhiping ;

Boice, Judith ;

Huyck, Susan ;

Comillie, Freddy .

JOURNAL OF CROHNS & COLITIS, 2017, 11 (06) :680-689

[14] American Gastroenterological Association Institute Technical Review on the Use of Thiopurines, Methotrexate, and Anti-TNF-α Biologic Drugs for the Induction and Maintenance of Remission in Inflammatory Crohn's Disease [J].

Dassopoulos, Themistocles ;

Sultan, Shahnaz ;

Falck-Ytter, Yngve T. ;

Inadomi, John M. ;

Hanauer, Stephen B. .

GASTROENTEROLOGY, 2013, 145 (06) :1464-+

[15] T-Cell Non-Hodgkin's Lymphomas Reported to the FDA AERS With Tumor Necrosis Factor-Alpha (TNF-α) Inhibitors: Results of the REFURBISH Study [J].

Deepak, Parakkal ;

Sifuentes, Humberto ;

Sherid, Muhammed ;

Stobaugh, Derrick ;

Sadozai, Yama ;

Ehrenpreis, Eli Daniel .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (01) :99-105

[16] Is There a Risk of Lymphoma Associated With Anti-tumor Necrosis Factor Drugs in Patients With Inflammatory Bowel Disease? A Systematic Review of Observational Studies [J].

Ferraro, Sara ;

Leonardi, Luca ;

Convertino, Irma ;

Blandizzi, Corrado ;

Tuccori, Marco .

FRONTIERS IN PHARMACOLOGY, 2019, 10

[17] Tumor necrosis factor a inhibitor therapy and cancer risk in chronic immune-mediated diseases [J].

Haynes, Kevin ;

Beukelman, Timothy ;

Curtis, Jeffrey R. ;

Newcomb, Craig ;

Herrinton, Lisa J. ;

Graham, David J. ;

Solomon, Daniel H. ;

Griffin, Marie R. ;

Chen, Lang ;

Liu, Liyan ;

Saag, Kenneth G. ;

Lewis, James D. .

ARTHRITIS AND RHEUMATISM, 2013, 65 (01) :48-58

[18] Role of Thiopurine and Anti-TNF Therapy in Lymphoma in Inflammatory Bowel Disease [J].

Herrinton, Lisa J. ;

Liu, Liyan ;

Weng, Xiaoping ;

Lewis, James D. ;

Hutfless, Susan ;

Allison, James E. .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 (12) :2146-2153

[19] Transmembrane TNF-α: structure, function and interaction with anti-TNF agents [J].

Horiuchi, Takahiko ;

Mitoma, Hiroki ;

Harashima, Shin-ichi ;

Tsukamoto, Hiroshi ;

Shimoda, Terufumi .

RHEUMATOLOGY, 2010, 49 (07) :1215-1228

[20] Cancer Risk in Inflammatory Bowel Disease According to Patient Phenotype and Treatment: A Danish Population-Based Cohort Study [J].

Jess, Tine ;

Horvath-Puho, Erzsebet ;

Fallingborg, Jan ;

Rasmussen, Henrik H. ;

Jacobsen, Bent A. .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (12) :1869-1876

← 1 2 3 4 5 →